Medical Know How

IMPRESSION – A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly

IMPRESSION – A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly
IMPRESSION – A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly

Concept Medical Inc., focused on vascular intervention drug delivery devices, has updated the progress of IMPRESSION (sIroliMus coated balloon angioPlasty versus plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION) randomised trial.

IMPRESSION is a prospective, multi-center, two-arm parallel group, randomised clinical trial to compare the efficacy of Sirolimus Coated Balloon versus Placebo Plain Balloon (control arm) in the treatment of dysfunctional (stenosed) fistula used for vascular access in hemodialysis. A total of 170 patients with End Stage Renal Disease (ESRD) are being randomised in 1:1 fashion (MagicTouch AVF: Placebo Plain Balloon).

The study’s primary objective is to determine if the use of Sirolimus Coated Balloon will result in an improvement of the primary circuit patency at six months when compared head-to-head with plain balloon angioplasty (POBA). The MagicTouch AVF Sirolimus Coated Balloon has already been granted the Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). Only ESRD patients with a matured dysfunctional arterio-venous fistula (AVF) that has been in use for at least one month prior to angioplasty will be enrolled.

The study is being conducted at three sites in Singapore led by Associate Professor Chieh Suai Tan, Head and Senior Consultant, Department of Renal Medicine, Singapore General Hospital (SGH), as the principal investigator. Other site principal investigators include Associate Professor Edward Choke, Senior Consultant, Department of Surgery, Sengkang General Hospital, and Associate Professor Jackie Ho, Senior Consultant, Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore. The index patient was enrolled on 11th January 2021 and at the time of going to press, 37 patients have been enrolled.

SGH was chosen to lead this randomised controlled trial because of its prior experience using Sirolimus Coated Balloon in two investigator-initiated pilot studies. The studies had shown that patency rates with the use of MagicTouch AVF in thrombosed arterio-venous graft (AVG) and dysfunctional AVF were 65 per cent and 82.9 per cent at six months, respectively.

An operational vascular access such as AVF or (AVG) is vital in ESRD patients for effective and long-term hemodialysis. Unfortunately, due to various reasons, the AVF or AVG may narrow (stenosis), resulting in poor flow of the vascular access, which affects hemodialysis. The functional life of an AVF is poor with as high as 50 per cent chance of failure after a median of three to seven years.

Singapore has one of the highest ESRD incident rates globally. POBA is the current standard treatment for patients with AVF stenosis. Despite the minimally invasive nature of POBA procedure, the long-term patency is poor, averaging 40 to 50 per cent at one year. This necessitates multiple procedures in order to maintain patency of the vascular access.

Paclitaxel Coated Balloon is also being used to treat dysfunctional AVF with mixed success. However, the safety concerns of Paclitaxel raised by the U.S. FDA and the issue of guidelines by the interventional societies have prompted doctors to seek a better alternative.

SOURCE Concept Medical

Thailand announced the ‘Medical Hub’ project in 2003. This project aimed to make Thailand the center of healthcare treatment of Asia. It was because the booming trend of medical tourism in the country. Travel that acquires for medical surgeries such as knee operation, breast augmentation or cosmetic surgeries, has become a trending activity for foreign tourism, who wishes to use the change of atmosphere to recharge their energy during the recovery period.

ในปี 2003 ประเทศไทยได้ประกาศเริ่มต้นโครงการ “ศูนย์กลางทางการแพทย์” หรือ Medical Hub โครงการนี้ทำให้ประเทศไทยเป็นฮับของการรักษาพยาบาลของทวีปเอเชีย โครงการนี้มีไว้เพื่อรองรับการเติบโตอย่างต่อเนื่องของการท่องเที่ยวเพื่อสุขภาพ หรือ medical tourism ในประเทศไทย การท่องเที่ยวเพื่อสุขภาพ คือ การเดินทางเพื่อรับการรักษาพยาบาล เช่น ผ่าตัดหัวเข่า ผ่าตัดเสริมหน้าอก หรือทำศัลยกรรม การท่องเที่ยวลักษณะนี้เป็นที่นิยมของชาวต่างชาติ ที่ต้องการเปลี่ยนบรรยากาศในการผักผ่อนและพักฟื้นร่างกาย

From 2009 – 2014, the number of foreign medical tourists in Thailand grew 10.96%, which was as high as 2.5 million people. Since 2008, the business has generated over 120 billion Baht of annual income to the country. Thai government would like to strengthen the industry by making a national policy. “Thailand, a Hub of Wellness and Medical Services”, the policy was implemented in 2016. It is a ten-year strategy, which aims Thailand to be a medical in four areas; wellness, medical services, academics and medical products by 2025.  The Thai government provided 14% of the total budget to healthcare industry, which is the highest among the ASEAN countries. It shows how strong the focus is as a national policy.

นับจากปี 2009 – 2014 จำนวนของนักท่องเที่ยวเพื่อสุขภาพในเมืองไทยเติบโตขึ้น 10.96% นับได้ถึง 2.5 ล้านคน ตั้งแต่ปี 2008 เป็นต้นมา การท่องเที่ยวเพื่อสุขภาพสร้างรายได้มากกว่า 120,000 ล้านบาทต่อปี นั่นทำให้รัฐบาลไทยต้องการสานต่อความสำเร็จนี้ ด้วยการทำให้มันนโยบายแห่งชาติ นโยบายนี้มีชื่อว่า “ศูนย์กลางสุขภาพนานาชาติ” ซึ่งเริ่มดำเนินงานตั้งแต่ปี 2016 โครงการนี้มีระยะเวลา 10 ปี ที่ต้องการพัฒนาการแพทย์ของไทยใน 4 ด้าน ประกอบไปด้วย ด้านสุขภาวะ การให้บริการทางการแพทย์ ด้านวิชาการ และผลิตภัณฑ์ทางการแพทย์ ภายในปี 2025 รัฐบาลไทยได้จัดสรรปันส่วน 14% ของงบประมาณทั้งหมดไปให้กับอุตสาหกรรมด้านสุขภาพ ซึ่งถือเป็นงบประมาณที่สูงที่สุดในเอเชียตะวันออกเฉียงใต้ นั่นแสดงให้เห็นถึงความจริงจังของนโยบายนี้

Affordability, support from the government (as a national policy), professionalism, service quality, knowledge of holistic and alternative treatments, complete treatment packages, accessibility (very few procedures required for entrance), and most importantly beautiful tourist destinations, these are the attributes that undoubtedly make Thailand one of the best choices for medical tourism. 

ราคาที่จับต้องได้, การสนับสนุนจากรัฐบาล (ในฐานะนโยบาย), บุคลากรมืออาชีพ, คุณภาพการให้บริการ, ความรู้ด้านการแพทย์ทางเลือก, การสร้างแพ็คเกจบริการที่น่าใช้, การเข้าถึงได้ง่าย (เช่น ขอวีซ่าเข้าประเทศได้ง่าย) และ สถานที่ท่องเที่ยวมากมาย นี่คือคุณสมบัติสำคัญที่ทำให้ประเทศไทยเป็นหนึ่งในดินแดนชั้นนำด้านการท่องเที่ยวเพื่อสุขภาพ 

First of all, living cost in Bangkok is more than three time cheaper than the developed countries. Also, the cost for medical treatments in Thailand is 40 – 70% lower than those offered in western countries and Australia. Receiving quality treatments with this extremely cost-effective price attracts thousands of tourists each year. 

ค่าครองชีพในกรุงเทพมหานครนั้นถูกกว่าประเทศที่พัฒนาแล้วประมาณ 3 เท่า และค่าใช้จ่ายในการรักษาของประเทศไทยนั้นต่ำกว่าประเทศตะวันตกและออสเตรเลียถึง 40%-70% การได้รับการรักษาพยาบาลคุณภาพสูงในราคาไม่แพงทำให้นักท่องเที่ยวต่างชาติต่างพากันมาประเทศไทยในแต่ละปี

Thailand also has a world-class medical training. The country has over 50,573 well-trained physicians in diverse field of treatments, with more than 1,000 public and 300 private hospitals nationwide. The Thai physicians have been globally accepted. Most of the medical professionals working in medical tourism are qualified by medical associations of US and/or more than two countries. The Thai professionals have been praised in these areas; general examinations, dentistry, cancer treatments, kidney transplants, cardio testing, heart surgeries, Laser eye surgeries, cosmetic surgeries, weigh loss surgeries, sex change operations and balloon dilatation. 

ประเทศไทยยังมีการฝึกสอนทางการแพทย์ที่ได้รับการยอมรับจากทั่วโลก เรามีแพทย์ที่ผ่านการรับรองมากถึง 50,573 คนที่มีความเชี่ยวชาญเฉพาะทางที่หลากหลาย และมีโรงพยายาลรัฐมากกว่า 1,000 แห่ง และโรงพยาบาลเอกชนมากกว่า 300 แห่งทั่วประเทศ แพทย์ของไทยได้รับการยกย่องจากทั่วโลก และแพทย์ที่ทำงานด้านการท่องเที่ยวเพื่อสุขภาพส่วนใหญ่ผ่านการรับรองจากแพทยสมาคมของสหรัฐอเมริกาและประเทศอื่นๆ ความเชี่ยวชาญของแพทย์ไทยได้รับคำชื่นชมจากทั่วโลกในด้านต่างๆ ดังนี้ การตรวจโรคทั่วไป, ทันตกรรม, การรักษามะเร็ง, การปลูกถ่ายไต, การตรวจวัดการเต้นของหัวใจ, การผ่าตัดหัวใจ, การผ่าตัดตาด้วยเลเซอร์, ศัลยกรรม, การผ่าตัดเพื่อลดน้ำหนัก, การผ่าตัดแปลงเพศ และการทำบอลลูนหัวใจ 

Thai hospitality has been widely perceived as the world’s best. The hospitality in Thai medical tourism makes this business stand out from its regional competitors. Millions of foreign tourists come to Phayathai Hospital and Bangkok Hospital each year to receive 5-star services. They include many things like 1) studio apartment size rooms for patient with free Wi-Fi that come with decorated living room, washroom and kitchen to stay with family or travel partner. 2) Lounges that offer alcohol free drinks. 3) Check-in receptions with professional customer service. 4) In-house travel agent to cater visa extensions. 5) Translator services for international patients

การบริการของชาวไทย ถูกยกย่องให้ติดอันดับต้นๆ ของโลก การบริการที่ใส่ใจเป็นจุดแข็งที่ทำให้การท่องเที่ยวเพื่อสุขภาพในประเทศไทยโดดเด่นกว่าประเทศอื่นในภูมิภาค นักท่องเที่ยวนับล้านมาเข้ารับบริการทางการแพทย์ระดับห้าดาวที่โรงพยาบาลพญาไทและโรงพยาบาลกรุงเทพในแต่ละปี โรงพยาบาลชั้นนำมาพร้อมกับสวัสดิการดึงดูดใจมากมาย เช่น 1) ห้องพักขนาดสตูดิโอ ที่มาพร้อมกับสัญญาณอินเตอร์เนท และห้องนั่งเล่นที่ตกแต่งอย่างดี 2) บาร์เครื่องดื่มที่ปลอดแอลกอฮอล์ 3) พนักงานต้อนรับและระบบบริการลูกค้าอย่างมืออาชีพ 4) มีบริการพาไปเที่ยวและทำเรื่องขอวีซ่า 5) ล่ามและนักแปลหลากหลายคู่ภษา 

Also, many websites offered a built-in engine that the tourists can book the flight and the hotel while browsing the hospitals. Some of the healthcare center is located inside a hotel. Such services make coming to Thailand for medical treatments friendly to the potential client.

นอกจากนี้ยังมีว็บไซต์รวบรวมโรงพยาบาลที่รองรับ medical tourism ในเว็บนั้นมีระบบจองตั๋วเครื่องบินและโรงแรมเสร็จสรรพในตัว สถานพยาบาลบางแห่งก็ตั้งอยู่ในโรงแรมเลย ซึ่งช่วยอำนวยความสะดวกให้กับนักท่องเที่ยวเป็นอย่างมาก 

The foreign tourists do not come to Thailand only for modern medical treatments, many of them go for holistic and alternative treatments such as acupuncture, facial rejuvenation, cupping and moxibustion. These treatments are offered in leading hospitals and healthcare centers. 

นักท่องเที่ยวต่างชาติไม่ได้มาเยือนเมืองไทยเพื่อรับการรักษาแผนปัจจุบันเท่านั้น หลายคนเข้ารับการรักษาแบบแพทย์ทางเลือก เช่น ฝังเข็ม บำรุงผิวหน้า ถ้วยกัวซา และการรมยาสมุนไพร การรักษาแบบนี้มีให้บริการในสถานพยาบาลชั้นนำทั่วประเทศ

Moreover, apart from single treatment services, Thai hospitals offer bundling services of specialized treatment, which keep the patients in Thailand longer. And that will help boost the tourism. For example, dental implants are offered with discounted dental cosmetic treatments with free dental consultation. Because of a large number of medical specialists in Thailand, such offerings make Thai medical services realize their full potential.

 นอกจากการรักษาพยาบาลเฉพาะทางแล้ว โรงพยาบาลในประเทศไทยยังทำแพ็คเกจให้บริการเป็นคอร์สต่างๆ เพื่อให้นักท่วงเที่ยวใช้เวลาในประเทศไทยยาวนานขึ้น ซึ่งช่วยส่งเสริมอุตสาหกรรมการท่องเที่ยว ตัวอย่างเช่น การปลูกรากฟันเทียม ที่มาพร้อมกับคอร์สจัดฟัน และการให้คำปรึกษาฟรี ประเทศไทยมีแพทย์เฉพาะทางอยู่จำนวนมาก ทำให้การสร้างแพ็คเกจบริการทางการแพทย์ทำได้ง่ายและมีคุณภาพสูง

Another advantage for Thailand is visa exemption. The medical tourists need no visa to enter Thailand. They can stay up to 30 days without visa required. Also, if the tourists need to stay longer than a month, hospital staff will take care of the paperwork, so the tourist worry nothing. 

ข้อได้เปรียบอีกประการหนึ่งคือการออก visa on arrival ให้กับนักท่องเที่ยวเพื่อสุขภาพ นักท่องเที่ยวเพื่อสุขภาพสามารถอยู่ในเมืองไทยได้นานถึง 30 วันโดยไม่ต้องขอวีซ่า และถ้าต้องการอยู่เกิน 30 วัน ก็มีพนักงานคอยจัดการเรื่องเอกสารให้ โดยนักท่องเที่ยวไม่ต้องกังวล

Lastly, Thailand has plenty of tourist destinations. In Bangkok, many hospitals are located near BTS train stations or located near tourist attractions like a night market. The tourists can contact hotel staff to provide them car plus driver to take them on tour throughout Bangkok and nearby provinces. If the tourists want to travel outside Bangkok, it can be done within one hour by plane. This is a plus for Thailand. 

ประเทศไทยเป็นดินแดนสำคัญด้านการท่องเที่ยว สถานพยาบาลหลายแห่งตั้งอยู่ตามแนวรถไฟฟ้า BTS หรือใกล้กับสถานที่ท่องเที่ยว เช่น ไนท์มาร์เกต นักท่องเที่ยวสามารถติดต่อพนักงานโรงแรมเพื่อเช่ารถพร้อมคนขับให้พาไปเที่ยวจังหวัดข้างเคียงได้อย่างสะดวกสบาย

It is undeniable that these factors help Thailand to become a world’s leading country for medical tourism. Now, the growth of medical tourism, as part of Medical Hub Policy, is positive. How to maintain the market share and quality treatments are the keys to further improvement of this industry. 

ปัจจัยเหล่านี้ล้วนส่งเสริมให้ประเทศไทยเป็นประเทศชั้นนำของโลกด้านการท่องเที่ยวเพื่อสุขภาพ และการเติบโตของอุตสาหกรรมการท่องเที่ยวเพื่อสุขภาพ ที่เป็นส่วนหนึ่งของนโยบายศูนย์กลางทางการแพทย์ อยู่ในทิศทางที่ดี และจำเป็นต้องหาทางรักษาคุณภาพของการรักษาเพื่อขับเคลื่อนอุตสาหกรรมนี้ให้ก้าวต่อไป

What to expect when your newborn needs special care

IMPRESSION – A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly
Photos courtesy of Getty Images

(Family Features) If you have a baby who is born too early or has serious health problems, he or she may be admitted to the neonatal intensive care unit (NICU), a hospital unit that provides around-the-clock specialized care to newborns.

The NICU can be an overwhelming place with lots of machines, hospital staff and medical terms. If you or someone close to you is pregnant, understanding what to expect if a NICU stay is required can help you focus less on the surroundings and uncertainty and more on taking care of the new baby and yourself.

Learn the ins and outs of the NICU with information from March of Dimes, the nation’s leading nonprofit that advocates for the health of all moms and babies, which partners with hospitals across the country through its NICU Family Support® program to provide in-person and online support for families with babies in the NICU.

Common NICU Conditions

Babies born too early and other sick newborns may face a variety of medical issues. Among common causes for a NICU stay may include preterm birth, complications during labor and delivery, birth defects, genetic conditions or other illnesses.

Tests to Expect in the NICU

Your baby may have tests and monitoring done in the NICU to determine health conditions and treatments for him or her to grow and be healthy. Some tests, like blood tests, are common. Others are just for babies with certain health conditions. Depending on his or her condition, your baby might need scans or imaging to find out what’s happening, like a CT scan, echocardiogram, MRI, ultrasound or X-ray. You can also expect various screenings for vision and hearing, and monitoring for things like weight changes and urine tests, which can tell health care providers about your baby’s overall condition.

Coping with Stress in the NICU

When your baby is in the NICU, it may be hard to think about taking care of yourself. However, taking care of yourself can help you stay well and have more energy to spend time with your baby.

  • Stick to a daily routine. Every day, take a shower, eat regular meals, drink plenty of water and get a good night’s sleep. As part of your routine, decide when you want to be with your baby in the NICU. Schedule breaks from the NICU. It’s OK to make time for yourself and the rest of your family.
  • Follow COVID-19 protocols while connecting with other NICU families at NICU classes, in the family lounge or in the NICU hallways. They may understand what you’re experiencing and be able to offer guidance. You can find a supportive online environment that provides advice and resources, and allows you to connect with communities of other NICU families that have had similar experiences, at marchofdimes.org/online-communities.aspx.
  • You may experience many emotions when your baby’s in the NICU. Talking to a counselor may help you sort through your feelings. This may be someone from the NICU staff, a social worker or your religious or spiritual leader. Sometimes it’s helpful to talk to someone trained to help you work through stress and navigate challenges like going back to work, the baby blues or postpartum depression.

Paying for Your Baby’s NICU Stay

Health insurance helps pay for medical care. You may get health insurance from your employer, from the government or buy it on your own. If your insurance doesn’t cover all the health care costs for your baby, ask the NICU social worker or case manager about your options. A social worker can assist you with finding resources and services to help care for your baby. You can also meet with the hospital’s finance department about setting up a payment plan. A case manager may also oversee a baby’s discharge from the hospital and help set up home care services and supplies, if needed.

Learn more about the NICU and find articles and resources for your family at marchofdimes.org/NICU.

Answers at Your Fingertips

Having a newborn in the NICU can be overwhelming. You’re likely to have lots of questions and need access to tools that help you through the NICU stay. You can learn about NICU staff, policies, equipment and terminology on your own schedule with the March of Dimes My NICU Baby App, which provide answers, tools and support so you can focus on your baby during what is often a difficult time.

The app (available for iOS and Android devices) was developed to help parents cope with a baby’s early birth, complications like birth defects and other issues that may lead to a NICU stay. It includes features like tracking breastfeeding sessions, breast pumping and kangaroo care time, taking photos and connecting with other families with similar experiences.

Life After the NICU

It can be hard to get used to being at home with your baby after a stay in the NICU. These tips can help you adjust to life at home with your baby:

  • When you have questions about your baby or your baby’s care, call your child’s pediatrician.
  • Take your baby to all his or her well-child visits. These are medical checkups where your baby’s health care provider checks his or her health and development to make sure things are going well.
  • Ask family members, friends and neighbors for help at home. Tell them exactly what you need them to do. For example, tell them if you need help with the laundry, running errands or taking care of your other children.
  • Take extra steps to keep your baby healthy while he or she is building an immune system, especially during cold and flu season. Limit the number of visitors and only welcome those who are healthy. Ask visitors to wash their hands before touching the baby. Do not allow smoking near your child.

NanoTemper Enters Protein Production Market With Andromeda, Helping Biopharma and CROs to Increase Efficiency of Expression Screening for Membrane Proteins

NanoTemper Enters Protein Production Market With Andromeda, Helping Biopharma and CROs to Increase Efficiency of Expression Screening for Membrane Proteins

NanoTemper Technologies, well-known for creating biophysical tools that tackle challenging characterizations, enters the protein production market with the release of Andromeda, an instrument that determines optimal expression levels and thermal stability of recombinant membrane proteins in crude lysates — something unachievable using currently available methods or technologies on their own. As a result, Andromeda increases the efficiency of protein production teams at CROs and Biopharma, who now arrive at purification much faster and with the most stable proteins because they have insights on thermal stability during expression screening.

“Protein production teams promise to deliver high-quality recombinant proteins, and when affinity screening campaigns or crystallization protocols fail, the blame usually falls on them. Andromeda helps them deliver on that promise more quickly and efficiently,” says Stefan Duhr, co-CEO of NanoTemper.

“To select for the best expression conditions, protein production teams currently focus mostly on expression levels, while protein stability characterization is carried out separately or after purification. This involves a combination of methods like SDS-PAGE, FSEC, and FSEC-TS, which can be tedious and have a low throughput.” shared Jocelyn Davé, Chief Product Officer at NanoTemper. “Andromeda, on the other hand, reveals expression levels and stability characterization from a single assay in crude lysates before teams commit to purification.”

With Andromeda, protein production teams can now hand over high-quality proteins faster and save themselves the trouble of rescreening by knowing the stability of proteins early on. Andromeda provides all the valuable information needed to help them quickly and efficiently select for conditions that result in high expression levels of quality proteins.

Visit nanotempertech.com/andromeda to find out more details. For the most up-to-date information, follow NanoTemper on LinkedIn, Facebook, and Twitter.

NanoTemper Enters Protein Production Market With Andromeda, Helping Biopharma and CROs to Increase Efficiency of Expression Screening for Membrane Proteins
BitePRO Version 4 Bite Resistant Armguards worn by a nurse

According to protective clothing manufacturer, BitePRO, specifically designed protective clothing for health care professionals, as well as patients and service users, will help reduce the use of force within mental health care.

Well documented incidents related to the use of force, control, and restraint by those in a position of care have recently made global headlines. Including instances of excessive force within care, special needs, and mental health units.

BitePRO offers protective clothing to assist in reducing instances of restraint and force when undergoing manual handling of individuals exhibiting behaviours that challenge.

BitePRO also wishes to support the promotion of a human rights-based approach to the use of force, giving front line professionals tools to help them to work closely with patients and develop therapeutic environments which ensure that force is used as a last resort.

Following customer feedback, the potential of discreet protective clothing for staff as an essential step toward reaching this goal has been recognised and the demand for protective clothing in mental health care was established.

This demand was found after an international customer survey where the clothing manufacturer highlighted that 92% of participants found that their staff felt more confident de-escalating upon wearing the company’s protective garments.

Senior Product Consultant Rachel Riding says: “To allow staff to feel safer de-escalating, reducing the need for the use of force and restraint, they should be given access to personal protection as a matter of priority.”

She continues: “We hope that they will be able to confidently diffuse a situation where they, or the patient, are at risk of injury and trauma before reaching crisis point.”

BitePRO has already supplied a considerable amount of grab bags, containing the most popular garment models, to hospitals, special education, and mental health units globally.

For further information please contact BitePRO directly: [email protected]

NanoTemper Enters Protein Production Market With Andromeda, Helping Biopharma and CROs to Increase Efficiency of Expression Screening for Membrane Proteins
iHerb launches a promotional event during April

With April here before we realize it, many are already making travel plans and developing a routine for getting back in shape, signaling their pursuit of a happier and healthier lifestyle. The demand for nutritional supplements that enhance health is on the rise alongside the awareness of the necessity for regularly-scheduled physical exercise now that warmer weather is with us.

Global online retailer iHerb recently launched a promotional event that will last until the end of April. To provide shoppers across the world’s different time zones the best discounts this spring, the event consists of daily promotions (from 10:00 am Mondays (US Pacific Time) to 10:00 am Thursdays) and weekend promotions (from 10:00 am Fridays to 10:00 am Mondays), with discounts of at least 20 per cent. In addition, shoppers are also entitled to an additional 5 per cent off by placing orders during the promotional period using the discount code BDU9188.

US-based e-commerce company iHerb has provided high-quality, cost-effective, healthy products made with natural ingredients to more than 150 countries and regions worldwide through its online platform since 1996. Currently, the company has established a number of GMP-certified modern green warehousing facilities in California, Kentucky and Pennsylvania as well as Incheon, South Korea, providing stocking and packaging services to the over 1,200 selected brands and 30,000 products available on the platform.

NanoTemper Enters Protein Production Market With Andromeda, Helping Biopharma and CROs to Increase Efficiency of Expression Screening for Membrane Proteins

The April promotional event includes a rich line-up of nutritional supplements that meet the expectations of shoppers with a wide range of needs.

1.  California Gold Nutrition, Hydrolyzed Marine Collagen Polypeptide, Natural Flavor, 7.05 oz. (200 g)

Product Code: CGN-01863

CGN collagen is the brand’s signature supplement with the newly launched version containing upgraded ingredients. The legacy product is a combination of cod and tilapia (African crucian carp), while the upgraded version is made of 100 per cent wild cod, delivering a purer and more reassuring product. The collagen polypeptide extracted from sea fish can be easily absorbed, so even men can use it safely without being concerned about issues associated with animal feed and hormones. Collagen offers a higher level of absorption and utilization after being hydrolyzed into amino acids and peptides. Taking collagen before going to bed is highly beneficial in helping keep the skin taut and smooth as well as preserving joints and bones.

2. MuscleTech, Essential Series, Platinum-Level Full Omega Fish Oil, 100 Soft Capsules

Product Code: MSC-60448

MuscleTech, an exquisitely packaged fish oil, is rich in DHA and EPA which are the essential omega-3 fatty acids and play an important role in boosting the metabolism. The product is mainly made from anchovies. Each capsule contains a moderate level of 300mg DHA and EPA and features the enteric coating design that removes fishy smells and helps eliminate inflammation caused by workouts.

3. Jarrow formulas, Jarrosil, Activated Silicon, 2 oz. (60 ml)

Product Code: JRW-13017

JarroSil’s Activated Silicon delivers outstanding performance in promoting skin rejuvenation. Using JarroSil’s patented silicon formula with high bioactivity and stable silicic acid clusters, the product improves the skin’s elasticity and reduces wrinkles by stimulating collagen production. Adequate silicon helps hair and nails grow thicker and stronger while playing an important role in bone calcification. With a daily intake of just 10 drops, the product with an acidulous taste helps create softer and smoother skin and improve dry heels. It also acts as an agent for healthier hair by helping ensure fast and smooth hair growth.

4. Desert Essence, Tea Tree Oil Skin Ointment, 1 fl. oz. (29.5 ml)

Product Code: DES-00003

The Dessert Essence Tea Tree Oil Moisturizing Cream is rich in vitamin E and contains natural essence oil along with lavender essential oil which helps soothe stressed skin. Combining essential oil with herbs, it helps relieve allergic and dry skin in addition to preventing cracked skin on the face or body. With tea tree essential oil, the cream can also be used as a multi-purpose ointment, with an anti-inflammatory and healing effect on small skin wounds. It has been proved especially useful in repairing skin tears and irritation caused by shaving in addition to healing chapped hands and feet. This product is suitable for all types of skin.

5. Mild By Nature, Thickening B-Complex + Biotin Shampoo by Madre Labs(R), No Sulfates, Citrus Squeeze, 16 fl. oz. (473 ml)

Product Code: MBN-01259

The organic shampoo, one of the brand’s best-sellers, is safe for use as it is a non-GMO product, free of synthetic flavors, glutenin, P-hydroxybenzoate and phthalates. It is also pH-balanced and cruelty-free. When used frequently, the nutritious shampoo cleans the hair while rendering it thicker, fuller and healthier looking. The B-complex and biotin help improve the health of both the hair and the scalp. In addition, the shampoo contains vegetarian quinoa and flax protein (which strengthen the hair), aloe leaf juice (which helps soothe the scalp and the hair follicles), and essence oil blends (which offer fresh citrus scents and make the hair look more natural).

A complete list of the products featured in the promotional event can be viewed on the official website, as well as on iHerb’s global and China apps.

The China app is available for download at https://img.iherb.cn/app/app.html?channelCode=HY while the global app can be downloaded by searching “iHerb” in the App Store. Shoppers in mainland China who place orders using the Wechat mini program are also entitled to an additional 2 yuan (approx. US$0.30) to 888 yuan (approx. US$133) discount via Wechat red envelope.

iHerb provides discounts on a rich line-up of products as part of its promotional event until the end of April

SOURCE iHerb

Zero-Contact Medical Station for a Safe and Rapid PCR Covid-19 Testing


Zero-Contact Medical Station for a Safe and Rapid PCR Covid-19 Testing
Zero-Contact Medical Station, the robotic technology for COVID-19 testing, innovated by Brain Navi Biotechnology from Taiwan. (PRNewsfoto/Brain Navi Biotechnology Co., Ltd.)

Brain Navi Biotechnology Co., Ltd., a brain surgery robotic company, is launching “zero-contact” medical stations in hospitals across Taiwan, fully protect medical staff and patients from the cross-infection of “highly contagious diseases.” The biggest risk of infection for medical staff is during intubation, nasal swabbing, and personal protective equipment (PPE) removal, says Dr. Jerry Chen, the Brain Navi CEO. He adds that “Since the SARS crisis in Asia 17 years ago, there was no advancement in the protection technology for medical staff. How could medical staff protect us if they are not well protected in the first place?”. As a physician himself with a full understanding of the frontline medical staff’s anxiety, this motivates Dr. Chen to reimagine testing for infectious diseases using robotics, enabling zero-contact between medical staff and patients.

The Zero-Contact Medical Station with robotics technology is creating a new normal of Covid-19 testing in Taiwan. Medical staff and patients stay in an isolated chamber with safety features, including HEPA filter, UVC lamps, a ventilation system, and a negative 8 Pa air pressure. Under medical staff’s control and supervision, a Nasal Swab Robot performs the nasopharynx specimen collection. This allows the medical staff to achieve nasal swabbing without patient contact and eliminates the need to wear a PPE. Nasal Swab Robot just obtained the CE mark with Class I.

The Zero-Contact Medical Station achieves zero-contact swabbing and pipetting tasks for lab technicians. After swabbing, an automated robot will then pipette the collected specimen and prepare an essay for PCR diagnosis. The robotic systems are integrated with Roche’s RT-PCR device allowing automatic and efficient process. The entire testing process from robot’s collection to result generation can be done in 25 minutes.

Through robotics automation and consolidation of PCR lab and diagnosis in one medical station, the Zero-Contact Medical Station protects medical staff and minimizes precious staffing, improves lab testing capacity, and reduces transport and reporting time.

The zero-contact features and rapid PCR testing with minimal staffing make this station an ideal solution for large-scale testing at public venues such as cruise ships, stadiums, and airports, allowing your country to reopen the economy or commence the travel bubble with safety measures. To find out more about the Zero-Contact Medical Station, please visit our website https://brainnavi.com/zerocontactstation/.

www.brainnavi.com

Zero-Contact Medical Station for a Safe and Rapid PCR Covid-19 Testing

In an effort to treat patients currently suffering from COVID-19, researchers from Feinstein Institutes are collaborating on new clinical studies with biopharmaceutical leaders Gilead Sciences, Regeneron and Sanofi

The Feinstein Institutes for Medical Research, the research arm of Northwell Health, announced today the enrollment of three clinical trials in the ongoing effort to combat COVID-19, the novel coronavirus.

Feinstein Institutes researchers are teaming up with Gilead Sciences, Regeneron Pharmaceuticals and Sanofi to identify effective treatments for patients currently hospitalized in moderate and severe conditions with COVID-19. The goal is to improve recovery and speed discharge from hospitals. The three Feinstein Institutes trials are offered to patients already admitted to Northwell Health hospitals with moderate to severe COVID-19. The trials are not currently available to the general public.

“We’ve joined with three outstanding companies to immediately begin clinical trials for patients now suffering from COVID-19 and are determined to do all we can to stop the virus in its tracks,” said Michael Dowling, president and CEO of Northwell Health.

While there is a nationwide push for an expedited Food and Drug Administration (FDA) approval process of these and other experimental COVID-19 therapies, Northwell Health and the Feinstein Institutes prioritize the safety of patients. The process of these formal trials will lead to accurate testing of these novel drugs prior to mainstream use.

With Gilead, the Feinstein Institutes will conduct two trials looking at the safety and efficacy of remdesivir (RDV), an investigational antiviral drug, designed to reduce the intensity and duration of COVID-19 in hospitalized patients. RDV has demonstrated positive effects on other viral pathogens such as MERS and SARS in vitro and in animal models. The first trial can accommodate up to 400 severe cases of COVID-19 globally and is a randomized study of two different durations of treatment with RDV, delivered intravenously. Researchers will look at clinically relevant endpoints in patients with severe manifestations of disease. The lead investigator on this study is Marcia Epstein, MD, Feinstein Institutes researcher and an infectious disease expert.

The other RDV trial in collaboration with Gilead is also a phase 3 study that will assess two different durations of treatment with RDV as compared to current standard of care in up to 600 patients with moderate COVID-19 globally. Researchers will look at clinical endpoints and time to discharge. The lead investigator on this study is Prashant Malhotra, MD, assistant professor in the Institute of Health Innovations & Outcomes Research at Feinstein, and an infectious disease expert.

In collaboration with Regeneron Pharmaceuticals and Sanofi, the Feinstein Institutes will conduct an adaptive randomized trial for approximately 400 severe or critical patients being hospitalized for the virus in multiple sites across the US. It will look at the safety and efficacy of sarilumab, a human antibody that may prevent the activity of a specific cytokine called interleukin-6 (IL-6) that is thought to be important in the development of complications of severe pneumonia in some COVID-19 patients.

The role of IL-6 is supported by preliminary data from a Chinese trial and based on those results which showed rapid reductions in fever in all patients, China recently updated its COVID-19 treatment guidelines and approved the use of that IL-6 inhibitor to treat patients with severe or critical disease. The study that the Feinstein Institutes will participate in is the first controlled trial in the U.S. to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients. The lead investigator on this study is Negin Hajizadeh, MD, assistant professor in the Institute of Health Innovations & Outcomes Research at Feinstein, and a pulmonary and critical care physician.

“As history has shown from past pandemics, medical research will lead in our nation’s ability to reverse the fatal spread of viruses,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes. “By teaming up with these outstanding pharmaceutical leaders, our researchers have the opportunity to help beat the Coronavirus by delivering cutting-edge care through clinical research at our Northwell Health hospitals.”

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 2,500 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit feinstein.northwell.edu.

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, about 750 outpatient facilities and more than 13,600 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 70,000 employees – 16,000-plus nurses and 4,000 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We’re training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Saint-Gobain Life Sciences, an industry leader in material science-based solutions for cell and gene therapy manufacturing, today launched a new cell culture bag designed specifically for T cell derived therapies.

Zero-Contact Medical Station for a Safe and Rapid PCR Covid-19 Testing

T cell based therapies are revolutionizing the approach to treating cancer. Harnessing the patient’s own immune system by isolating their T cells and engineering them to elicit an immune response is emerging as a preferred manufacturing practice. As the industry continues the advancement of these therapies, process efficiency becomes paramount to the success of delivering affordable therapies to patients.

Building upon the VueLife® family of fluorinated ethylene propylene (FEP) based cell culture bags, VueLife® “HP” (high permeability) incorporates an innovative, patented laminate film layer that allows increased CO2 and O2 exchange versus other monolayer bag designs, yet maintains the scalability and process flexibility offered by a closed bag system. The increased permeability associated with the “HP” laminate layer was specifically designed for culturing cells requiring higher rates of respiration, such as T cells.

“The development of this product was in direct response to the market need for a cost effective culture vessel that provides efficient cell expansion in a scalable, closed system,” said Benjamin Le Quere, General Manager for the Saint-Gobain Life Sciences Bioprocess Solutions business unit. “VueLife® “HP” is an exciting result of the marrying of our expertise in material science with our knowledge in cell culture.”

The entire family of VueLife® cell culture bags utilize a common FEP fluid-contact layer. FEP creates an ideal environment for cell growth due to its gas permeability and liquid impermeability, while being biologically and chemically inert.

ABOUT SAINT-GOBAIN LIFE SCIENCES

Dedicated to improving the quality of life, Saint-Gobain Life Sciences develops and manufactures high-performance components and integrated solutions that touch a broad range of patient care, from the development of new therapeutic cancer treatments to biopharmaceutical production, on through to intravenous therapies for drug delivery.

Along with material science expertise and collaborative design services, our focus on global quality and regulatory affairs allow us to be the trusted partner to organizations reaching every part of the globe. Combining our technical expertise, global manufacturing capabilities and research and development resources, Saint-Gobain Life Sciences is dedicated to meeting the evolving needs of bioprocess, medical and pharmaceutical customers around the world. Saint-Gobain Life Sciences is part of Compagnie de Saint-Gobain.

Compagnie de Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change. Saint-Gobain operates in 70 countries with more than 180,000 employees worldwide. The Company had €42.6 billion in sales in 2019.

www.celltherapy.saint-gobain.com/products/cell-culture-processing-bags/vuelife-hp-series

Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System

Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has introduced the Nuewa I9, its latest cart-based ultrasound system and tailored solution for Obstetrics and Gynecology (OB/GYN). Committed to inspiring women’s healthcare, Mindray’s Nuewa I9 elevates scanning capacity to new levels by combining innovative design and exceptional imaging quality with the latest technologies.

Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System
Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System (PRNewsfoto/Mindray)

“Nuewa I9 offers an unrivaled ultrasound scanning experience in its class. Each feature and innovation have been deliberately designed to address the daily challenges of OB/GYN clinicians. The result is a full-stack smart solution for extraordinarily efficient care, which covers the entire continuum from pre-pregnancy to obstetrics and post-partum,” said He Xujin, General Manager of Mindray Imaging System Division.

Nuewa I9 boasts a well-thought-out design for the ultimate convenience. Its foldable height and compact body allow the system to easily pass through doors for quick access across departments. Meanwhile, the breakthrough exam-specific iConsole control panel is optimized to adapt to different clinical scenarios, and its E-ink keys can be easily customized for the most frequently used functions.

The entire solution is powered by Mindray’s revolutionary ZST+ platform, which overcomes traditional trade-off limitations to deliver exceptional image quality for infinite imaging solutions with non-stop improvements. Nuewa I9 is also packed with automated tools to improve workflow and efficiency in women’s and neonatal care, such as Smart-VTrace, Smart Pelvic and Smart Hip.

One of the biggest innovations featured in Mindray’s Nuewa I9 is Smart Scene 3D, a scenario-oriented volume scan technique that enables the automatic identification of tissue characteristics and provides an organ-specific diagnosis. The technology supports the whole examination procedure starting with auto clinical scenario identification, then harnesses automation at every point from imaging optimization to plane acquisition, quantification, and the creation of an automated workflow. As a result, Nuewa I9 alleviates the workload of manual operation; reduces scanning time for individual patients; and delivers a truly easy, accurate and fast diagnosis.

Nuewa I9 also makes 3D/4D interactions extremely intuitive with reduced knob adjustments. Clinicians need only to click and choose their desired effect for different application scenarios, such as Routine, iLive, Bone, Tissue, and Follicle. Preset imaging settings have been integrated in the system for optimal volume imaging effects, and support ease of use in every possible clinical scenario for OB/GYN.

SOURCE Mindray

Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System

It’s part of the company’s mission to equip its Medicare Advantage members with easy-to-use tools and resources to manage their health and live healthier lives

CarePlus Health Plans, Inc., Florida’s largest* Medicare Advantage plan rated 5 out of 5 stars for 2021, and Sharecare, the digital health company that helps people manage all their health in one place, are collaborating to make it easier for CarePlus Medicare Advantage members across Florida to take an active role in improving their health.

“We’re thrilled to team with Sharecare to inspire our members to live their healthiest lives possible, no matter where they are on their health journey,” said Bruno Piquin, CarePlus Health Plans President. “Access to Sharecare will help our members more easily manage their health and well-being in one place, track their progress, and get rewarded along the way.”

Sharecare’s digital health experience, which includes an easy-to-use mobile app, enables CarePlus members to go from assessment to action. The digital experience starts with the RealAge® test, Sharecare’s clinically validated health risk assessment that shows members the true age of their bodies. It then provides personalized action plans to guide and educate members on health factors that may impact longevity and real-time tracking of daily health goals.

All CarePlus Medicare Advantage plans now offer access to Sharecare. CarePlus members can also use Sharecare to track and redeem CarePlus Rewards for completing certain healthy activities. The CarePlus Rewards program is offered to members free of charge.

“There is an opportunity to leverage the power of personal technology to help Medicare beneficiaries gain better access to care and increase utilization of the critical resources available to them,” said Pam Shipley, Chief Operating Officer at Sharecare. “At Sharecare, we are fiercely committed to bringing much needed scalable innovation to health care, and we are excited to partner with CarePlus by empowering their members to take control of their personal health and well-being, right in the palm of their hand.”

Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System

Ultraviolet (UV) technology developed by the New York-based firm PurpleSun Inc. eliminates more than 96 percent of pathogens in operating rooms (ORs) and on medical equipment, compared to 38 percent using manual cleaning methods that rely on chemicals to disinfect surfaces, according to a study published this month in the American Journal of Infection Control (AJIC).

Health care is in constant battle to maintain a clean and pathogen-free patient care environment. To improve quality and reduce risk, hospitals use established protocols for cleaning and disinfecting ORs and medical equipment with chemical wipes after each case. Medical equipment ranges from surgical robots, microscopes and scanners to patient beds and stretchers.

“The challenge from an infection control standpoint is that microbes and bacteria are invisible to the human eye, and there is potential for errors in the manual cleaning and disinfection process, whether it’s attributable to inadequate staffing, poor training, lack of adherence to manufacturers’ instructions or other human error,” said Donna Armellino, RN, DNP, vice president of infection prevention at Northwell Health, who was the lead author on this study. Among other factors, for instance, the disinfectants may have the wrong dilution, be incompatible with the materials used to clean, may not be in contact with the equipment long enough, or the chemicals may be improperly stored, reducing their pathogen-destroying effectiveness, she said.

To assess the current standard of cleaning and disinfection in ORs, Northwell clinicians teamed with PurpleSun, which developed a focused multivector, ultraviolet (FMUV) device that is used to supplement manual cleaning. FMUV takes 90 seconds to fully disinfect surfaces. They evaluated the current standard of cleaning in the OR with and without the use of FMUV.

As part of the study, researchers assessed pathogen presence by performing tests on equipment that was reported out in colony-forming units (CFUs). CFUs represent pathogens that could potentially increase the risk of a hospital-acquired infection. The testing was done before manual cleaning, after manual-chemical cleaning and disinfection, and after the automated FMUV light technology using a five-point assessment technique. The aggregate CFUs following manual-chemical disinfection compared to pre-cleaning showed a 38 percent effectiveness at killing pathogens, whereas the process using FMUV was 96.5 percent effective at reducing the level of reported CFUs.

“The study supports the fact that operating rooms are clean, but not as clean as we’d like following manual chemical cleaning and disinfection. FMUV has the potential for changing the cleanliness of operating rooms,” said Dr. Armellino. Her co-authors on the study were Kristine Goldstein, RN, and Linti Thomas, RN, of Northern Westchester Hospital; and Thomas J. Walsh, MD, and Vidmantas Petraitis, MD, both of Weill Cornell Medicine of Cornell University.

The American Journal of Infection Controlis the clinical journal of the Association of Professionals in Infection Control.

Northwell Health is an investor in PurpleSun’s technology, and is currently using the technology in ORs at Northern Westchester Hospital in Mount Kisco and Staten Island University Hospital, as well as the neonatal intensive care unit at Cohen Children’s Medical Center in New Hyde Park.

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, about 750 outpatient facilities and more than 13,600 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 70,000 employees – 16,000-plus nurses and 4,000 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We’re training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Viraleze registered for sale in Covid-ravaged India

India’s vast population will have access from today to the Australian developed anti-COVID nasal spray Viraleze following its registration in the country.

Viraleze registered for sale in Covid-ravaged India

The announcement came as the world’s second most populous country battles a devastating second wave of COVID-19 infections, with over 29 million cases and 363,000 deaths. Yesterday, India set a new global record for deaths after 6,148 people died in the previous 24 hours.

Developed by biopharmaceutical company Starpharma, Viraleze has shown to inactivate a broad-spectrum of respiratory viruses, including more than 99.9% of coronavirus SARS-CoV-2 (the virus that causes COVID-19). The product can be applied either before or after exposure and can be used in high-risk or crowded environments up to four times a day.

Importantly for a largely rural population like India’s, the spray can be stored at room temperature and does not require cold storage or specialised transportation.

Indian consumers can purchase the spray from www.viraleze.co and Starpharma’s discussions with commercial partners in India for distribution into both the private (consumer) and Government markets are well advanced.

“India continues to record hundreds of thousands of COVID-19 cases every day. Starpharma has worked extremely hard to achieve expedited registration of Viraleze given the significant need,” said Starpharma’s CEO, Dr Jackie Fairley.  

“The active in Viraleze, astodrimer sodium, has been shown to be highly active against multiple strains and variants of SARS-CoV-2, including the problematic Alpha variant, which is the second most common variant in India and has been responsible for COVID-19 cases in about 135 countries.”

Viraleze™ first launched in the UK at LloydsPharmacy in March and was the biggest selling product ever at LloydsPharmacy.com. It launched in Europe in early May.

Starpharma has received interest from more than 30 countries since launching its webstore, including from Japan where the Olympics hosted next month, and has been in the grip of a fourth wave of COVID-19 infections.

Viraleze™ has also been ordered by several international sporting teams, including Olympic teams. Starpharma has signed a partnership agreement for Viraleze™ with the Harlequins rugby union team in the UK which are using the product as part of its COVID-19 prevention protocols. 

Viraleze™ complements other COVID-19 prevention strategies, including vaccines. It has special relevance in areas of high population density, and where social distancing is not possible and in high-risk environments such as travel, hotel quarantine, and sporting events.

SOURCE Starpharma

Viraleze registered for sale in Covid-ravaged India
Viraleze registered for sale in Covid-ravaged India
iHerb launches a promotional event during April

With April here before we realize it, many are already making travel plans and developing a routine for getting back in shape, signaling their pursuit of a happier and healthier lifestyle. The demand for nutritional supplements that enhance health is on the rise alongside the awareness of the necessity for regularly-scheduled physical exercise now that warmer weather is with us.

Global online retailer iHerb recently launched a promotional event that will last until the end of April. To provide shoppers across the world’s different time zones the best discounts this spring, the event consists of daily promotions (from 10:00 am Mondays (US Pacific Time) to 10:00 am Thursdays) and weekend promotions (from 10:00 am Fridays to 10:00 am Mondays), with discounts of at least 20 per cent. In addition, shoppers are also entitled to an additional 5 per cent off by placing orders during the promotional period using the discount code BDU9188.

US-based e-commerce company iHerb has provided high-quality, cost-effective, healthy products made with natural ingredients to more than 150 countries and regions worldwide through its online platform since 1996. Currently, the company has established a number of GMP-certified modern green warehousing facilities in California, Kentucky and Pennsylvania as well as Incheon, South Korea, providing stocking and packaging services to the over 1,200 selected brands and 30,000 products available on the platform.

Viraleze registered for sale in Covid-ravaged India

The April promotional event includes a rich line-up of nutritional supplements that meet the expectations of shoppers with a wide range of needs.

1.  California Gold Nutrition, Hydrolyzed Marine Collagen Polypeptide, Natural Flavor, 7.05 oz. (200 g)

Product Code: CGN-01863

CGN collagen is the brand’s signature supplement with the newly launched version containing upgraded ingredients. The legacy product is a combination of cod and tilapia (African crucian carp), while the upgraded version is made of 100 per cent wild cod, delivering a purer and more reassuring product. The collagen polypeptide extracted from sea fish can be easily absorbed, so even men can use it safely without being concerned about issues associated with animal feed and hormones. Collagen offers a higher level of absorption and utilization after being hydrolyzed into amino acids and peptides. Taking collagen before going to bed is highly beneficial in helping keep the skin taut and smooth as well as preserving joints and bones.

2. MuscleTech, Essential Series, Platinum-Level Full Omega Fish Oil, 100 Soft Capsules

Product Code: MSC-60448

MuscleTech, an exquisitely packaged fish oil, is rich in DHA and EPA which are the essential omega-3 fatty acids and play an important role in boosting the metabolism. The product is mainly made from anchovies. Each capsule contains a moderate level of 300mg DHA and EPA and features the enteric coating design that removes fishy smells and helps eliminate inflammation caused by workouts.

3. Jarrow formulas, Jarrosil, Activated Silicon, 2 oz. (60 ml)

Product Code: JRW-13017

JarroSil’s Activated Silicon delivers outstanding performance in promoting skin rejuvenation. Using JarroSil’s patented silicon formula with high bioactivity and stable silicic acid clusters, the product improves the skin’s elasticity and reduces wrinkles by stimulating collagen production. Adequate silicon helps hair and nails grow thicker and stronger while playing an important role in bone calcification. With a daily intake of just 10 drops, the product with an acidulous taste helps create softer and smoother skin and improve dry heels. It also acts as an agent for healthier hair by helping ensure fast and smooth hair growth.

4. Desert Essence, Tea Tree Oil Skin Ointment, 1 fl. oz. (29.5 ml)

Product Code: DES-00003

The Dessert Essence Tea Tree Oil Moisturizing Cream is rich in vitamin E and contains natural essence oil along with lavender essential oil which helps soothe stressed skin. Combining essential oil with herbs, it helps relieve allergic and dry skin in addition to preventing cracked skin on the face or body. With tea tree essential oil, the cream can also be used as a multi-purpose ointment, with an anti-inflammatory and healing effect on small skin wounds. It has been proved especially useful in repairing skin tears and irritation caused by shaving in addition to healing chapped hands and feet. This product is suitable for all types of skin.

5. Mild By Nature, Thickening B-Complex + Biotin Shampoo by Madre Labs(R), No Sulfates, Citrus Squeeze, 16 fl. oz. (473 ml)

Product Code: MBN-01259

The organic shampoo, one of the brand’s best-sellers, is safe for use as it is a non-GMO product, free of synthetic flavors, glutenin, P-hydroxybenzoate and phthalates. It is also pH-balanced and cruelty-free. When used frequently, the nutritious shampoo cleans the hair while rendering it thicker, fuller and healthier looking. The B-complex and biotin help improve the health of both the hair and the scalp. In addition, the shampoo contains vegetarian quinoa and flax protein (which strengthen the hair), aloe leaf juice (which helps soothe the scalp and the hair follicles), and essence oil blends (which offer fresh citrus scents and make the hair look more natural).

A complete list of the products featured in the promotional event can be viewed on the official website, as well as on iHerb’s global and China apps.

The China app is available for download at https://img.iherb.cn/app/app.html?channelCode=HY while the global app can be downloaded by searching “iHerb” in the App Store. Shoppers in mainland China who place orders using the Wechat mini program are also entitled to an additional 2 yuan (approx. US$0.30) to 888 yuan (approx. US$133) discount via Wechat red envelope.

iHerb provides discounts on a rich line-up of products as part of its promotional event until the end of April

SOURCE iHerb

While it has advanced exponentially over the last couple of decades, there is still a long way to go. It is an integral part of the diagnostic process. The medical imaging has been established successful being used by a number of entities to put away their important patient and research records.

Most imaging IT initiatives fail due to a deficiency of effective governance. Modernizing enterprise imaging can help improve the total stream of data in today’s complex healthcare networks.

Cloud technology doesn’t seek to alter the practice of producing medical images, but rather how they’re stored, shared, and read. Current medical imaging technology exists in the shape of large and costly systems in hospitals in the network firewalls. Cloud computing also raises the accuracy of reimbursement coding. The newest technology in the specialty is called a graphical processing unit (GPUs).

SaaS applications are usually very mobile and support a wide array of client devices.  Irrespective of your hardware, the procedure is transparent and the outcomes are standardized. The PACS-to-VNA migration processes is also complicated because of the essence of the DICOM format, that has been in use for at least 20 decades. The cloud migration procedure, though, can be daunting for healthcare organizations since they must move a slew of data.

When employing the DICOM viewer, there’s no new software to be set up.  The medical software should be approved by bodies like FDA and health care bodies of distinct countries so that it may be used globally. At present, the medical imaging software is now an essential part of the diagnostic machines to supply the better-quality images in shorter times.

Many businesses also supply compatibility with non-DICOM images which makes it simpler to view and get non-compatible images. Disruption with digital Lastly, some businesses are finding inspiration in digital native small business models and new technologies from beyond the healthcare arena to extend a foundation for disruptive digital strategies that possess the capability to revolutionize conventional market wants and behavior.

Cloud providers are currently offering a number of new strategies to access information via cloud applications and microsites made for mobile devices. Many cloud providers have begun offering HIPAA-specific compliant solutions. Measured service The services are charged by the medical cloud service provider in accord with the sum of resources used. Every cloud PACS provider should make it simple for its clients to deal with their cloud medical imaging data.

The chance for superior communication amongst providers, along with increased patient access to qualified radiologists, could end up being an important benefit. The advantages of cloud computing could possibly be minimized by the assumption that cloud services are essentially exactly the same.

The other huge advantage of cloud computing for the medical record storage business is the minimal cost and big storage capabilities.

The other huge advantage of cloud computing for the medical record storage business is the minimal cost and big storage capabilities. The hospital would like to begin utilizing the system since they have a brief time frame to digitize the radiology information record system. It blamed a shortage of radiologists. Many hospitals utilize medical imaging equipment that’s unavailable to small clinics and underprivileged locations or third world countries because of the expenses of that equipment. As a business, healthcare is behind the times in regards to using technology.

http://online-dicom-viewer.over-blog.com/importance-of-cloud-medical-imaging-technology-for-healthcare.html

Product Quality is of the Utmost Importance, Visitors to the ICMD Impressed by ICP DAS-BMP Medical Grade TPU

Product Quality is of the Utmost Importance, Visitors to the ICMD Impressed by ICP DAS-BMP Medical Grade TPU
2021 ICMD Exhibition (PRNewsfoto/ICP DAS Co., Ltd.)

The 31st International Component Manufacturing & Design Show (ICMD) took place from May 13 to 16, 2021 at the Shanghai National Convention and Exhibition Center. The event was a big success, with industry heavyweights in attendance.

The ICMD exhibition aims to promote the complete integration of the industry’s upstream and downstream industrial chains, particularly in the high-end manufacturing supply chain of medical devices. After years of planning, ICP DAS-BMP made a low-key debut at this international event.

Dr. Chen, vice president of Medical-grade Polymers Division in ICP DAS-BMP, brought approximately 80 models of the three major series of medical-grade TPU to the exhibition in Hall 8.1, including hardness from 70A to 85D, transparency to barium sulfate content of 20% (B20) or 40% (B40), together with several color specifications. ICP DAS-BMP medical grade TPU, on the other hand, impressed ICMD attendees with its high quality.

Throughout the four-day event, the ICP DAS-BMP booth was bustling with visitors. The ICP DAS-BMP attracted a large number of visitors, who came to talk and consult, as well as exhibitors and professionals. In the front of the booth, there was an endless stream of visitors. Not only were materials and samples distributed, but many viewers also applied for samples on the spot. This time, there are nearly 200 visitors, and more than ten large-scale plastic material agents have expressed strong interest in the product agency.

In the medical materials market, TPU has become an unavoidable replacement for PVC. ICP DAS-BMP is committed to providing customers around the world with highly stable medical grade TPU. ICP DAS-BMP has spent the last four years focusing on medical grade TPU research and development, launching three series of Alithane ALP, Durathane ALC, and Arothane ARP, which are widely used in medical equipment. Many countries, including Europe, the United States, Ukraine, and India, have applied for trial materials, with positive outcomes. At the same time, over 20 Taiwanese companies have used the ALP, ALC, and ARP series for new product development.

Not only has ICP DAS-BMP medical grade TPU passed the USP Class VI biological safety test, but it has also passed the ISO 10993-4 hemolysis test, ISO 10993-5 in vitro cytotoxicity test, ISO 10993-10 skin irritation and sensitivity test, ISO 10993-11 acute system toxicity test, and pyrogen test. Furthermore, before leaving the factory, each batch of products is subjected to a comprehensive polymer analysis, cytotoxicity testing, and processing evaluation to ensure consistent quality.

ICP DAS-BMP (Official Website: https://bmp.icpdas.com/) will rely on its strong research and development team to define a new vision and paradigm for interpreting the power of science and technology in order to provide the medical materials market with more abundant, complete, and consistent quality options, as well as to share a world of business opportunities.

SOURCE ICP DAS Co., Ltd.

Engineers, medical people, scientific people, have an obsession with solving the problems of reality, once you reach a basic level of wealth in create entire designs with

Engineers, medical people, scientific people, have an obsession with solving the problems of reality, once you reach a basic level of wealth in society, most problems are actually problems of perception.

Wider Galleries

  • Product Quality is of the Utmost Importance, Visitors to the ICMD Impressed by ICP DAS-BMP Medical Grade TPU
  • Product Quality is of the Utmost Importance, Visitors to the ICMD Impressed by ICP DAS-BMP Medical Grade TPU
  • Product Quality is of the Utmost Importance, Visitors to the ICMD Impressed by ICP DAS-BMP Medical Grade TPU

What does Gutenberg change in WordPress

The sole purpose of the Gutenberg editor is to provide an alternative to the current open text editor, not to mention the difficult-to-remember shortcodes, with an agile and visual user interface (UI). So, unlike the current WordPress editor, you don’t have to:

  • Import images, multimedia and approved files from the media library or add HTML shortcodes;
  • Copy and paste links for embeds;
  • Write shortcodes for specialized assets of different plugins;
  • Create featured images to be added at the top of a post or page;
Product Quality is of the Utmost Importance, Visitors to the ICMD Impressed by ICP DAS-BMP Medical Grade TPU

In short, Gutenberg doesn’t change how WordPress functions. It does, however, change the way website owners (or creators) interact with it. Instead of a whole lot of shortcodes and meta boxes, you will be using simple blocks.

There are three responses to a piece of design – yes, no, and WOW! Wow is the one to aim for.

Ann Johnes

The sole purpose of the Gutenberg editor is to provide an alternative to the current open text editor, not to mention the difficult-to-remember shortcodes, with an agile and visual user interface (UI).
So, unlike the current WordPress editor, you don’t have to:

In short, Gutenberg doesn’t change how WordPress functions. It does, however, change the way website owners (or creators) interact with it. Instead of a whole lot of shortcodes and meta boxes, you will be using simple blocks.

Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has introduced the Nuewa I9, its latest cart-based ultrasound system and tailored solution for Obstetrics and Gynecology (OB/GYN). Committed to inspiring women’s healthcare, Mindray’s Nuewa I9 elevates scanning capacity to new levels by combining innovative design and exceptional imaging quality with the latest technologies.

Product Quality is of the Utmost Importance, Visitors to the ICMD Impressed by ICP DAS-BMP Medical Grade TPU
Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System (PRNewsfoto/Mindray)

“Nuewa I9 offers an unrivaled ultrasound scanning experience in its class. Each feature and innovation have been deliberately designed to address the daily challenges of OB/GYN clinicians. The result is a full-stack smart solution for extraordinarily efficient care, which covers the entire continuum from pre-pregnancy to obstetrics and post-partum,” said He Xujin, General Manager of Mindray Imaging System Division.

Nuewa I9 boasts a well-thought-out design for the ultimate convenience. Its foldable height and compact body allow the system to easily pass through doors for quick access across departments. Meanwhile, the breakthrough exam-specific iConsole control panel is optimized to adapt to different clinical scenarios, and its E-ink keys can be easily customized for the most frequently used functions.

The entire solution is powered by Mindray’s revolutionary ZST+ platform, which overcomes traditional trade-off limitations to deliver exceptional image quality for infinite imaging solutions with non-stop improvements. Nuewa I9 is also packed with automated tools to improve workflow and efficiency in women’s and neonatal care, such as Smart-VTrace, Smart Pelvic and Smart Hip.

One of the biggest innovations featured in Mindray’s Nuewa I9 is Smart Scene 3D, a scenario-oriented volume scan technique that enables the automatic identification of tissue characteristics and provides an organ-specific diagnosis. The technology supports the whole examination procedure starting with auto clinical scenario identification, then harnesses automation at every point from imaging optimization to plane acquisition, quantification, and the creation of an automated workflow. As a result, Nuewa I9 alleviates the workload of manual operation; reduces scanning time for individual patients; and delivers a truly easy, accurate and fast diagnosis.

Nuewa I9 also makes 3D/4D interactions extremely intuitive with reduced knob adjustments. Clinicians need only to click and choose their desired effect for different application scenarios, such as Routine, iLive, Bone, Tissue, and Follicle. Preset imaging settings have been integrated in the system for optimal volume imaging effects, and support ease of use in every possible clinical scenario for OB/GYN.

SOURCE Mindray

BitePRO Clothing Aims to Reduce Control and Restraint in Mental Health Care

BitePRO Clothing Aims to Reduce Control and Restraint in Mental Health Care
BitePRO Version 4 Bite Resistant Armguards worn by a nurse

According to protective clothing manufacturer, BitePRO, specifically designed protective clothing for health care professionals, as well as patients and service users, will help reduce the use of force within mental health care.

Well documented incidents related to the use of force, control, and restraint by those in a position of care have recently made global headlines. Including instances of excessive force within care, special needs, and mental health units.

BitePRO offers protective clothing to assist in reducing instances of restraint and force when undergoing manual handling of individuals exhibiting behaviours that challenge.

BitePRO also wishes to support the promotion of a human rights-based approach to the use of force, giving front line professionals tools to help them to work closely with patients and develop therapeutic environments which ensure that force is used as a last resort.

Following customer feedback, the potential of discreet protective clothing for staff as an essential step toward reaching this goal has been recognised and the demand for protective clothing in mental health care was established.

This demand was found after an international customer survey where the clothing manufacturer highlighted that 92% of participants found that their staff felt more confident de-escalating upon wearing the company’s protective garments.

Senior Product Consultant Rachel Riding says: “To allow staff to feel safer de-escalating, reducing the need for the use of force and restraint, they should be given access to personal protection as a matter of priority.”

She continues: “We hope that they will be able to confidently diffuse a situation where they, or the patient, are at risk of injury and trauma before reaching crisis point.”

BitePRO has already supplied a considerable amount of grab bags, containing the most popular garment models, to hospitals, special education, and mental health units globally.

For further information please contact BitePRO directly: [email protected]

BitePRO Clothing Aims to Reduce Control and Restraint in Mental Health Care
The IDAI Immunization Task Force Sets Priorities for Covid-19 Vaccine Emergency Use
  • The emergency use authorization is only granted for limited use during the pandemic, not as a product distribution approval
  • Data on quality, both non-clinical and clinical, as well as the public health risks are the main considerations

Emergency use authorization (EUA) for a Covid-19 vaccine is one of the government’s efforts to stop the Covid-19 transmission chain. By prioritizing the safety, efficacy and quality of a Covid-19 vaccine, EUA can accelerate the pandemic mitigation. The implementation of these strategic policies and breakthrough steps are also the focus of the Covid-19 Handling and National Economic Recovery Committee (KPCPEN) which is also supported by the Indonesian Pediatrician Association (IDAI) Immunization Task Force.

Prof. Dr. dr. Cissy Rachiana Sudjana Prawira-Kartasasmita, Professor at the Padjajaran University School of Medicine, says, “Normally, new vaccine development takes a significant amount of time. However, the WHO has allowed efforts to accelerate Covid-19 vaccine development due to the urgent need under the pandemic.”

According to Prof. Prawira-Kartasasmita, who also serves as Chair of the Indonesian Pediatrician Association (IDAI) Immunization Task Force, the government has made every effort to stop the Covid-19 transmission chain. However, there are still many in the public who do not comply with health protocols which results in a soaring transmission rate. That is why we need a breakthrough to reduce virus transmission namely by means of a vaccine.

EUA Is Only Granted During The Pandemic, Not A Product Distribution Approval

One effort to expedite Covid-19 mitigation that is allowed is granting the Emergency Use Permit or EUA, as “The EUA is granted by regulatory bodies of each country. In Indonesia, EUA is under the authority of the National Agency of Drug and Food Monitoring (Badan Pengawas Obat dan Makanan/Badan POM). For the record, EUA is only granted for limited use during the pandemic, not as a product distribution approval. Of course, EUA also adheres to safety, efficacy and quality aspects,” explained Prof. Prawira-Kartasasmita.

She adds that the EUA weighs the benefit-to-risk ratio. On the other hand, the EUA provision involves all data of quality, both non-clinical and clinical, as well as the public health risks posed by the disease. Clinical trial data is very much needed to ensure the vaccine safety, efficacy as well as quality.

“According to the WHO, EUA for a vaccine is granted if at least 50% of volunteers have been fully vaccinated. Their health is monitored continuously for three months after their last injection. This also applies to (imported vaccines),” said Prof. (Prawira-Kartasasmita).

Previously, the Interim Deputy I at Badan POM Togi Hutadjulu explained that an EUA would be granted based on the consideration that the benefits outweigh the risks. The process of evaluating the safety and efficacy of a vaccine candidate involves the National Committee Team for Drug Evaluation (Tim Komite Nasional Penilai Obat), consisting of pharmacologists, clinicians, and experts in various fields. Badan POM would only be able to grant an EUA if a vaccine has met the safety, efficacy and quality requirements based on the evaluation process.

BitePRO Clothing Aims to Reduce Control and Restraint in Mental Health Care

Geberit Group, the European market leader in sanitary products, announces that Geberit Mapress Stainless Steel supply system is approved for use in Hong Kong. The stainless steel, non-soldered alternative is widely used in Asia as a safer, more durable alternative and replacement to lead piping and remove the risks of mixed metal supply systems.

Although banned by most countries in the use of drinking water systems since 1980, the high cost of replacement, lack of access to water supply and lack of awareness over the risks of mixed-metal piping mean contamination remains a danger. 

Mixed metal supply systems, when lead piping is connected to two other different metallic materials at both ends, usually steel and copper, can result in galvanic corrosion and poisoning of the water supply. 

In 2015, a lead contamination scare that occurred in Kai Ching Estate in Kowloon, which was traced back to mixed metal soldering as well as the discovery of excessive lead in the water supply for Kwai Tsui Estate in Kwai Fong in 2018, can cause severe health problems.

Following the scare, water industry experts highlighted that plumbing material control and commissioning requirements for new plumbing installations remain a crucial component ensuring the safety of water supply systems in the territory. As a result, each component must undergo strict testing to provide clean and safe building water supply. 

Geberit Mapress Stainless Steel reduces water contamination risk

The Geberit Mapress Stainless Steel range of products relies on a groundbreaking attachment technology that replaces soldering with mechanical joints, thus removing the risk of water contamination through subpar soldering techniques and materials. 

Its surgical-grade stainless steel components have high corrosion resistance and are the ultimate choice over the now-banned unlined galvanised steel pipes. The fittings are quick to install using only simple pressing technology and are permanently leakproof.

“A lack of awareness over mixed metal systems is a constant risk. However, through greater education of the risks and innovations, we can help eradicate the issue and ensure clean and safe supplies of water,” said Mr Desmond Lau, Regional Head – Hong Kong/Macau/Taiwan of Geberit North & South East Asia.

“Geberit’s extensive and dependable presence in European markets over many decades ensures that it is market-ready for Hong Kong. Removing dangerous components and the possibility of galvanic corrosion, Mapress Stainless Steel supply system is the ideal solution for building water supply systems, especially for users concerned about the possibility of lead contamination in the potable water supply for residences and workplaces,” Mr Lau added. 

In 2018, Geberit manufactured its billionth fitting, proving that it is a trusted and reliable water supply system provider in the industry. 

Henry Schein Donates More Than 2.5 Million Personal Protective Equipment and Infection Control Items to Non-Governmental Organizations for Front-line Health Care Workers in Brazil and India


Henry Schein Donates More Than 2.5 Million Personal Protective Equipment and Infection Control Items to Non-Governmental Organizations for Front-line Health Care Workers in Brazil and India

Donations to be Distributed through C.H. Robinson to Health Systems and Key Areas by Direct Relief, Heart to Heart International, IsraAid, MAP International, and Project HOPE

Henry Schein, Inc. (Nasdaq: HSIC), in partnership with C.H. Robinson and the C.H. Robinson Foundation, announced its commitment today to donate more than 2.5 million personal protective equipment (PPE) and infection control items through Henry Schein Cares, the Company’s corporate social responsibility program, to enhance the safety of front-line health care workers in Brazil and India as they combat the recent surge in COVID-19 cases.

The donation includes N95 face masks, level 1 face masks, level 2 face masks, coveralls, hand sanitizer, pulse oximeters, isolation gowns, and face shields. In collaboration with logistics partner C.H. Robinson, Henry Schein will distribute these products to several Non-Governmental Organizations (NGOs). The NGOs are then planning to redistribute the supplies to health systems and key areas in Brazil and India.

The recipients in India currently include the Baptist Hospital in Bangalore, LNJP Hospital in New Delhi, All India Institute of Medical Sciences in New Delhi, Deenanth Mangeshkar Hospital in Pune, Nair Hospital in Mumbai, and the State of Maharashtra. In Brazil, items will be distributed to health care workers in Rio de Janeiro and the State of Sergipe.

“It is critical that we help combat the rise in COVID-19 cases in Brazil and India, where the outbreak is particularly severe,” said Stanley M. Bergman, Chairman of the Board and CEO of Henry Schein, Inc. “Together with our NGO partners, we will continue the urgent task of enhancing the safety of the heroic health care professionals caring for patients battling the COVID-19 virus.”

Henry Schein’s NGO partners in this effort are as follows:

  • Direct Relief is a humanitarian aid organization, active in all 50 states and more than 80 countries, with a mission to improve the health and lives of people affected by poverty or emergencies – without regard to politics, religion, or ability to pay;
  • Heart to Heart International is a global humanitarian organization that improves access to health and responds to the needs of people affected by disasters worldwide;
  • IsraAIDis an Israel-based non-governmental organization that responds to emergencies all over the world with targeted humanitarian help;
  • MAP Internationalis a non-profit humanitarian organization providing medicines and health supplies to millions of people worldwide so they might experience life to the fullest; and
  • Project HOPE is a global health and humanitarian relief organization that is committed to placing power in the hands of local health care workers to save lives across the globe.

Engineers, medical people, scientific people, have an obsession with solving the problems of reality, once you reach a basic level of wealth in create entire designs with

Engineers, medical people, scientific people, have an obsession with solving the problems of reality, once you reach a basic level of wealth in society, most problems are actually problems of perception.

Wider Galleries

  • Henry Schein Donates More Than 2.5 Million Personal Protective Equipment and Infection Control Items to Non-Governmental Organizations for Front-line Health Care Workers in Brazil and India
  • Henry Schein Donates More Than 2.5 Million Personal Protective Equipment and Infection Control Items to Non-Governmental Organizations for Front-line Health Care Workers in Brazil and India
  • Henry Schein Donates More Than 2.5 Million Personal Protective Equipment and Infection Control Items to Non-Governmental Organizations for Front-line Health Care Workers in Brazil and India

What does Gutenberg change in WordPress

The sole purpose of the Gutenberg editor is to provide an alternative to the current open text editor, not to mention the difficult-to-remember shortcodes, with an agile and visual user interface (UI). So, unlike the current WordPress editor, you don’t have to:

  • Import images, multimedia and approved files from the media library or add HTML shortcodes;
  • Copy and paste links for embeds;
  • Write shortcodes for specialized assets of different plugins;
  • Create featured images to be added at the top of a post or page;
Henry Schein Donates More Than 2.5 Million Personal Protective Equipment and Infection Control Items to Non-Governmental Organizations for Front-line Health Care Workers in Brazil and India

In short, Gutenberg doesn’t change how WordPress functions. It does, however, change the way website owners (or creators) interact with it. Instead of a whole lot of shortcodes and meta boxes, you will be using simple blocks.

There are three responses to a piece of design – yes, no, and WOW! Wow is the one to aim for.

Ann Johnes

The sole purpose of the Gutenberg editor is to provide an alternative to the current open text editor, not to mention the difficult-to-remember shortcodes, with an agile and visual user interface (UI).
So, unlike the current WordPress editor, you don’t have to:

In short, Gutenberg doesn’t change how WordPress functions. It does, however, change the way website owners (or creators) interact with it. Instead of a whole lot of shortcodes and meta boxes, you will be using simple blocks.

เอกสารแสดงจุดยืนใหม่ที่เผยแพร่ผ่านวารสารAmerican Journal of Infection Control ออนไลน์ ได้กล่าวถึงการปรับปรุงวิถีปฏิบัติด้านสุขอนามัยในชีวิตประจำวัน เช่น การล้างมือ ว่ามีส่วนช่วยทำให้ความเสี่ยงของการติดเชื้อทั่วไปลดลง โดยมีหลักฐานที่ชี้ให้เห็นว่า การทำเช่นนั้น สามารถลดความเสี่ยงจากการติดเชื้อได้มากถึง 50% ด้วยเหตุนี้ ผู้เชี่ยวชาญด้านสาธารณสุขของ Global Hygiene Council (GHC) จึงออกมาเรียกร้องให้มีการใส่ใจกับการยกระดับพฤติกรรมการรักษาสุขอนามัยทั้งในบ้านและชุมชนให้มากขึ้น เพื่อชะลอการแพร่ระบาดของโรคติดเชื้อไวรัสโคโรนาสายพันธุ์ใหม่ (โควิด-19)

เอกสารแสดงจุดยืนฉบับนี้ซึ่งจัดทำขึ้นในนามของ GHC ได้ทำการสำรวจหลักฐานที่มาจากการปฏิบัติตามมาตรการสุขอนามัยภายในบ้านและชุมชนในชีวิตประจำวัน (รวมถึง สถานที่ทำงาน มหาวิทยาลัย โรงเรียน สถานเลี้ยงเด็ก ขนส่งสาธารณะ และระหว่างการซื้อสินค้า ตลอดจนการทำกิจกรรมสันทนาการต่าง ๆ ) และพบว่าพฤติกรรมดังกล่าวมีส่วนสำคัญในการควบคุมและชะลออันตรายจากการติดเชื้อจุลินทรีย์ที่ก่อให้โรค โดยมีการศึกษาหลายชิ้นที่แสดงให้เห็นว่า แบคทีเรียและไวรัสที่เป็นอันตรายส่วนมากสามารถส่งผ่านจากผู้ติดเชื้อไปยังผู้อื่นได้ผ่านทางมือและพื้นผิวที่ถูกสัมผัสบ่อยครั้ง และอยู่รอดเป็นจำนวนมากพอที่จะทำให้เกิดการติดเชื้อได้

การล้างมือและฆ่าเชื้อบนผิวสัมผัสเป็นประจำนั้นถูกจัดเป็นองค์ประกอบสำคัญของมาตรการด้านสุขอนามัยที่สามารถช่วยลดระดับของจุลินทรีย์บนมือและพื้นผิวที่ถูกสัมผัสบ่อยครั้งได้ ดังนั้น การรักษาความสะอาดในบ้านเรือน ตลอดจนระหว่างการใช้ชีวิตประจำวันของเรา จึงมีส่วนสำคัญในการช่วยเพิ่มการป้องกันการติดเชื้อในเวลาและสถานที่ที่มีความเสี่ยงต่อการแพร่ระบาดของเชื้อมากที่สุด

Jean-Yves Maillard ศาสตราจารย์ด้านจุลชีววิทยาทางเภสัชกรรมของคณะเภสัชศาสตร์แห่งมหาวิทยาลัยคาร์ดิฟฟ์ ซึ่งเป็นผู้เขียนหลัก ระบุว่า “จากสถานการณ์การแพร่ระบาดของโควิด-19 ในปัจจุบัน และหลักฐานที่ปรากฏอยู่ในเอกสารฉบับนี้ ชี้ให้เห็นว่า นี่เป็นเรื่องเร่งด่วนกว่าที่เคยสำหรับเราทุกคนที่จะตระหนักถึงบทบาทของสุขอนามัยชุมชนเพื่อลดการแพร่ระบาดให้น้อยที่สุด นอกจากนี้ การทำเช่นนั้นยังช่วยให้เราสามารถลดการใช้ยาปฏิชีวนะลงได้ และช่วยให้สามารถรับมือกับการดื้อยาด้วยเช่นกัน”

ในช่วงเวลาที่มีแต่ความวิตกกังวลเพิ่มขึ้นอยู่ตลอดเช่นทุกวันนี้ GHC จึงขอเรียกร้องให้หน่วยงานสาธารณสุขและผู้เชี่ยวชาญด้านการดูแลสุขภาพตระหนักถึงความสำคัญในการแนะนำประชาชนให้เห็นความจำเป็นของการรักษาความสะอาดในบ้านเรือนและชุมชนของพวกเขาเพื่อลดการแพร่กระจายของเชื้อไวรัสให้น้อยที่สุด

GHC ได้รับการสนับสนุนจาก RB ซึ่งเป็นผู้นำระดับโลกในด้านผลิตภัณฑ์สุขภาพและสุขอนามัย

อ้างอิง:

1. Curtis V, Cairncross S. Effect of washing hands with soap on diarrhoea risk in the community: a systematic review. Lancet Infect Dis. May 2003; 3 (5): 275-81

2. Staniford LJ, Schmidtke KA. A systematic review of hand-hygiene and environmental-disinfection interventions in settings with children. BMC Public Health 20, 195 (2020). Available at:https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-8301-0

3. International Scientific Forum on Home Hygiene. Containing the burden of infectious diseases is everyone’s responsibility. October 2018. Available from:https://www.ifh-homehygiene.org/sites/default/files/publications/IFH%20White%20Paper-10-18.pdf  Accessed April 6, 2020.

รูปภาพ – https://mma.prnewswire.com/media/1163611/Global_Hygiene_Council.jpg

https://en.prnasia.com/releases/apac/45756-0.shtml

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

Australian National Phenome Centre Integrates Quantitative NMR and MS Assay Platform for Risk Assessment and Longitudinal Monitoring of Post-Acute COVID-19 Syndrome (PACS)

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 disease phase. These biochemical abnormalities, identified by a quantitative, label-free assay platform integrating nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), relate to ongoing ‘long COVID’ symptoms, which persist post-acute infection and can affect more than half of the recovered COVID patients – even six months after infection.

A series of seminal papers on the molecular phenome of acute disease and post-acute COVID syndrome in patient plasma has been announced (https://medicalxpress.com/news/2021-05-covid-affecting-patients-months.html) and published (1-5) by the Australian National Phenome Centre (ANPC) at Murdoch University, in collaboration with other academic medical centers, and with Bruker Corporation (Nasdaq: BRKR) as a key technology partner.

The integrated, quantitative NMR and MS assay platform, which is for research use only, has revealed metabolic abnormalities, interactions of metabolic markers with cytokines, as well as interactions of lipoproteins with inflammation markers, caused by acute COVID-19. It enabled the creation of a multi-assay panel of pheno-conversion markers that change significantly during disease progression. This molecular phenomics panel can now also provide a measure of a patient’s partial recovery, or of emerging chronic PACS risks, e.g., for new-onset diabetes or for new-onset atherosclerosis, and for other persistent or reoccurring symptoms, including chronic fatigue, ‘brain fog’ and numerous other reported long COVID symptoms.

Post-acute follow up studies on non-hospitalized and mildly affected COVID-19 patients revealed that the majority of these patients is not back to normal health or normal biochemistry three months on and suffers from PACS, also referred to as ‘Long COVID’, characterized by persistent symptoms and health dysfunction after the acute infection. More than 57% of these patients show one or more symptoms up to six months following the acute phase, and many of them have metabolic abnormalities as revealed by the NMR and MS based pheno-reversion panel.

Professor Jeremy Nicholson, Pro Vice Chancellor for the Health Futures Institute at Murdoch University and Director of the ANPC explained: “Advanced NMR- and MS-screening of blood plasma provides complementary insights into the complex COVID-19 systemic pattern. There were multiple but variable biochemical abnormalities in the follow up patients with a variety of partial recovery phenotypes. We noted that most of the follow up COVID-19 patients had metabolic abnormalities irrespective of whether they were still symptomatic, but symptomatic patients were statistically more likely to have biochemical abnormalities.”

He continued: “This is an immensely dangerous disease that is not only costing lives today, but as we’re discovering now, may have serious health consequences for some patients long into the future, even in relatively mild original cases.”

The majority of patients at three months post-acute phase have a variety of blood metabolic abnormalities that differ between symptomatic and asymptomatic at six months. The researchers found that plasma lipoproteins in the blood of COVID-19 patients changed during infection and came closer to patterns typically found in patients with diabetes and atherosclerosis. Some abnormalities were reduced in the follow up patients and were reversible, whereas markers related to liver, energy metabolism and neuro-pathologies were often not completely reversed.

The latest research is consistent with earlier findings from the ANPC that showed COVID-19 is a systemic disease with multi-organ effects. The concept of pheno-conversion, as expressed in the lipoprotein and metabolic profile of blood plasma, establishes molecular phenotype biomarkers that can be analyzed for disease progression, severity and treatment. This underlines the importance of longitudinal studies on recovered patients for PACS effects and long-term health risks.

ANPC also devised a novel relaxation and diffusion edited NMR method that refined selectivity and led to the discovery of novel phospholipid signals from supramolecular clusters (3). “This is the first example of motional editing of complex blood plasma spectra to enhance the selectivity of a diagnostic procedure and opens the door to other NMR approaches to classification based on the dynamics of molecules, as well as on concentrations,” added Professor Nicholson.

Dr. Manfred Spraul, the CTO at Bruker BioSpin’s Applied, Industrial and Clinical Division, commented: “These findings underline the potential of our integrated NMR and MS assay platform for risk screening for PACS. Our research methods are robust and transferable for personalized molecular phenome signatures, providing a gateway to better understanding the long-term effects of COVID-19. These molecular phenotype insights are eventually expected to support better post-acute COVID-19 patient management for faster recovery, and a reduction in healthcare costs.”

The COVID-19 pheno-conversion and pheno-reversion signatures are detected by combined NMR and MS assays, providing complementary insights into potential biomarkers for cardiology, metabolism, diabetes, kidney disease, liver function, neurological effects, and inflammation.

Bruker has begun validation of this integrated NMR/MS clinical research assay set in Europe, with the goal of developing PACS personalized risk screening and longitudinal patient monitoring diagnostic methods.

Dr. Óscar Millet, Principal Investigator at CIC bioGUNE in Bilbao, Spain, commented: “As one of the key clinical research labs for precision medicine in Europe, we see huge potential for the PACS research enabled by high performance NMR and MS technology. We are an active member of the international COVID-19 research network, which is led by the ANPC. The harmonized research approach, which is based on standardized operating procedures developed by ANPC and Bruker, has allowed us to study PACS on Spanish patient cohorts and cross-validate our data with those of the ANPC at both the analytical and biological level.”

The studies were conducted using Avance™ IVDr NMR 600 MHz spectrometers integrated in the ANPC class II biosecurity laboratory, together with Bruker and CIC bioGUNE in-vitro diagnostics NMR research (IVDr) technology methods. The ANPC has also equipped its molecular phenomics lab with state-of-the-art mass spectrometers, including Bruker impact II and timsTOF™ Pro QTOF-MS, and a solariX™ MRMS system.

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

Read the 120-page research report with TOC on “Cannabis-based Alcoholic Beverages Market Analysis Report by Product (Cannabis-infused beers, Cannabis-infused spirits, and Cannabis-infused wines) and by Geography (APAC, Europe, North America, South America and MEA,), and Segment Forecasts, 2020 – 2024.”

The market is driven by the increasing social acceptance of cannabis. In addition, the growing prominence of online retailing is also anticipated to drive the cannabis-based alcoholic beverages market growth during the forecast period.

The commonly held perception about cannabis being a mere intoxicant have changed across several nations. Over the past five years, the global legal cannabis-based edibles and cannabis-based alcoholic beverages market has been posting robust growth, tempting new vendors and large investors to leverage the potential offered by this industry. The growth of the cannabis market has significantly added to the income of several governments and boosted sales and revenue of major corporations. Therefore, with such advantages, it is expected that the global market will face a positive outlook in the forecast period. Furthermore, the growing popularity of online retailing has enabled vendors to improve their profit margins. The number of online transactions and the average amount of money spent online per transaction is increasing worldwide, which will further boost market growth over the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Cannabis-based Alcoholic Beverages Market Companies:

Anheuser-Busch InBev

The company’s key business segments include North America, Latin America West, Latin America North, Latin America South, EMEA, and Asia Pacific. The company offers cannabis mixed beers.

California Dreamin’

The company produces and distributes natural cannabis beers.

CannaVines

The company offers cannabis infused wines such as Cannavines Red Blend x Headband, Cannavines Chardonnay x Sour Diesel, and Rose X Grand Daddy Purple.

MJ Wines LLC

The company operates in key business segments including Energy Drinks, Wine, Cold Brew Coffee. The company offers terpene infused energy shot, hemp and cannabis wine formulations, and hemp cold brew coffee. The company offers hemp and cannabis-based wine formulations.

Heineken NV

The company operates in key business segments including Europe, Americas, Africa, Middle East and Eastern Europe, Asia Pacific, and Heineken N.V. Head Office & Others. The company through its brand, Lagunitas Brewing Co. offers cannabis-based beer.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Cannabis-based Alcoholic Beverages Product Outlook (Revenue, USD Million, 2020 – 2024)

  • Cannabis-infused beers
  • Cannabis-infused spirits
  • Cannabis-infused wines

Cannabis-based Alcoholic Beverages Regional Outlook (Revenue, USD Million, 2020 – 2024)

  • APAC
  • Europe
  • North America
  • South America
  • MEA

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Consumer Staples are:

Global Alcoholic Beverages Market 2019-2023 – Global alcoholic beverages by product (beer, spirits, and wine) and geography (APAC, Europe, MEA, North America, and South America).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

The Montreal Heart Institute (MHI) today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with COVID-19 as recommended by the independent data monitoring committee (DMC), following a second interim analysis.

“With the dramatic rise in COVID-19 cases across the world, it is becoming even more critical that we continue to investigate treatments that can not only help those hospitalized with severe disease, but also those with less severe symptoms who are able to remain at home,” said Dr. Jean-Claude Tardif, Director of the Research Center at MHI, Professor of Medicine at the University of Montreal, and COLCORONA principal investigator. “We aim at completing patient recruitment in this large study within the next month and hope that colchicine will reduce the risk of COVID-19 complications.”

COLCORONA is a contact-free, at-home, randomized, double-blind, placebo-controlled study run out of Canada, the United States, Europe, South America, and South Africa. It aims to determine if colchicine can reduce the risk of serious complications linked to COVID-19. This is one of the few current large-scale studies of COVID-19 in which non-hospitalized patients can participate. Participants and physicians interested in COLCORONA can call the hotline at 1-877-536-6837.

COLCORONA is coordinated by the Montreal Health Innovations Coordinating Center (MHICC) and funded by the Government of Quebec, the Bill & Melinda Gates Foundation and the National Heart, Lung, and Blood Institute (NHLBI) of the United States National Institutes of Health (NIH). CGI, Dacima and Pharmascience are also collaborators of COLCORONA.

The Montreal Heart Institute and its partners worldwide would like to thank all the investigators and the thousands of participants for their continued participation in the COLCORONA study.

Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses


Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses

Vaccination activities build on collective success of COVID-19 response over the past year

As of today, 1,370 community pharmacies affiliated with Health Mart® and Health Mart Atlas™ have collectively administered 1 million COVID-19 vaccine doses.1 For underserved and rural communities, vaccine access can be a significant challenge in the initiative to reach every American. Community pharmacies play an integral role in leading vaccination administration in vulnerable areas. Health Mart, the nation’s third-largest pharmacy chain by store count, and Health Mart Atlas, a network of more than 7,000 member pharmacies, are comprised of local, independent pharmacies, participating in state and federal vaccination programs, including Health Mart’s Federal Retail Pharmacy Program. These pharmacists, and their staff, continue to be on the front lines of the COVID-19 response in their communities, many of which serve vulnerable populations. And, patients are grateful.

“Our pharmacy is the only outlet here that has the vaccine,” says Shad Williams, a Health Mart pharmacy patient in Adamsville, Tenn. “However, if there were a dozen different options, that’s where we would go. It’s a trust factor thing.” Williams also shared, “Our pharmacist was quick to get on the phone and let us know of its availability. He not only cares about us because we’re his customers, but because he has taken the time to get to know us. Which in my view, is a big deal.”

Activating with the U.S. government

More than 825 Health Mart pharmacies across 46 states are participating in Health Mart’s Federal Retail Pharmacy Program with the Centers for Disease Control and Prevention (CDC). Health Mart pharmacy teams are reaching some of the most vulnerable to COVID-19 according to the CDC’s social vulnerability index (SVI).

“I want to acknowledge the work the Health Mart team has done to make this program possible for our profession, but even more for the people of our county, state and Nation,” shared Jerry Duren, PharmD, pharmacist and owner of Duren’s Health Mart Pharmacy in Waynesboro, Tenn. “I know without a doubt it would not have been possible for us to provide this valuable life-saving service alone. It’s a service that is essential to so many of our patients.”

Several factors, including poverty, lack of access to transportation, and housing may weaken a community’s ability to prevent human suffering and financial loss in a disaster. These factors make up a community’s SVI. Duren’s pharmacy team is helping patients in Wayne County, a community with a 2018 overall SVI score of .77. Possible scores range from 0 (lowest vulnerability) to 1 (highest vulnerability).2

Essential support for essential work

Health Mart has facilitated COVID-19 vaccination training for more than 4,250 pharmacy staff members, secured 1,275 digital data loggers needed for proper vaccine storage and activated about 100 new stores a week. Health Mart also provided an online vaccine scheduler, a patient administration documentation tool, and a resource platform to centralize access to vaccine training, tools, and resources, and streamlined required daily activity reporting.

Moving the needle on vaccine hesitancy

Scott’s Health Mart Pharmacy – a Black-owned pharmacy serving Central Georgia since 1985 – is one of many pharmacy teams encouraging community acceptance of COVID-19 vaccines.

Pharmacist Wade Scott said, “The Black community’s distrust toward the vaccine has been built over the course of many years. But our goal is to let people know that this shot is safe and encourage skeptics to consider getting the shot.” To date, the pharmacy has administered 245 COVID-19 vaccinations, tested 1,140 patients for COVID-19 and continues the important public dialogue.

COVID-19 testing impact

In May 2020, select Health Mart pharmacies began COVID-19 test collection in partnership with an approved Department of Health and Human Services testing contractor, eTrueNorth. Participating Health Mart pharmacies offer free COVID-19 testing to patients and to date have collected more than 525,000 tests.

“From vaccinations to point-of-care testing to patient education – community pharmacies continue to be the compassionate and trusted provider you can lean on,” shared Eyad Farah, president Health Mart, Health Mart Atlas and Pharmacy & Healthcare Solutions. “They take the time to listen and care. So naturally, they are the problem solvers for America’s most complex healthcare issues and I’m beyond proud of their outstanding response during the COVID-19 pandemic.”

Engineers, medical people, scientific people, have an obsession with solving the problems of reality, once you reach a basic level of wealth in create entire designs with

Engineers, medical people, scientific people, have an obsession with solving the problems of reality, once you reach a basic level of wealth in society, most problems are actually problems of perception.

Wider Galleries

  • Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses
  • Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses
  • Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses

What does Gutenberg change in WordPress

The sole purpose of the Gutenberg editor is to provide an alternative to the current open text editor, not to mention the difficult-to-remember shortcodes, with an agile and visual user interface (UI). So, unlike the current WordPress editor, you don’t have to:

  • Import images, multimedia and approved files from the media library or add HTML shortcodes;
  • Copy and paste links for embeds;
  • Write shortcodes for specialized assets of different plugins;
  • Create featured images to be added at the top of a post or page;
Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses

In short, Gutenberg doesn’t change how WordPress functions. It does, however, change the way website owners (or creators) interact with it. Instead of a whole lot of shortcodes and meta boxes, you will be using simple blocks.

There are three responses to a piece of design – yes, no, and WOW! Wow is the one to aim for.

Ann Johnes

The sole purpose of the Gutenberg editor is to provide an alternative to the current open text editor, not to mention the difficult-to-remember shortcodes, with an agile and visual user interface (UI).
So, unlike the current WordPress editor, you don’t have to:

In short, Gutenberg doesn’t change how WordPress functions. It does, however, change the way website owners (or creators) interact with it. Instead of a whole lot of shortcodes and meta boxes, you will be using simple blocks.

Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses
The IDAI Immunization Task Force Sets Priorities for Covid-19 Vaccine Emergency Use
  • The emergency use authorization is only granted for limited use during the pandemic, not as a product distribution approval
  • Data on quality, both non-clinical and clinical, as well as the public health risks are the main considerations

Emergency use authorization (EUA) for a Covid-19 vaccine is one of the government’s efforts to stop the Covid-19 transmission chain. By prioritizing the safety, efficacy and quality of a Covid-19 vaccine, EUA can accelerate the pandemic mitigation. The implementation of these strategic policies and breakthrough steps are also the focus of the Covid-19 Handling and National Economic Recovery Committee (KPCPEN) which is also supported by the Indonesian Pediatrician Association (IDAI) Immunization Task Force.

Prof. Dr. dr. Cissy Rachiana Sudjana Prawira-Kartasasmita, Professor at the Padjajaran University School of Medicine, says, “Normally, new vaccine development takes a significant amount of time. However, the WHO has allowed efforts to accelerate Covid-19 vaccine development due to the urgent need under the pandemic.”

According to Prof. Prawira-Kartasasmita, who also serves as Chair of the Indonesian Pediatrician Association (IDAI) Immunization Task Force, the government has made every effort to stop the Covid-19 transmission chain. However, there are still many in the public who do not comply with health protocols which results in a soaring transmission rate. That is why we need a breakthrough to reduce virus transmission namely by means of a vaccine.

EUA Is Only Granted During The Pandemic, Not A Product Distribution Approval

One effort to expedite Covid-19 mitigation that is allowed is granting the Emergency Use Permit or EUA, as “The EUA is granted by regulatory bodies of each country. In Indonesia, EUA is under the authority of the National Agency of Drug and Food Monitoring (Badan Pengawas Obat dan Makanan/Badan POM). For the record, EUA is only granted for limited use during the pandemic, not as a product distribution approval. Of course, EUA also adheres to safety, efficacy and quality aspects,” explained Prof. Prawira-Kartasasmita.

She adds that the EUA weighs the benefit-to-risk ratio. On the other hand, the EUA provision involves all data of quality, both non-clinical and clinical, as well as the public health risks posed by the disease. Clinical trial data is very much needed to ensure the vaccine safety, efficacy as well as quality.

“According to the WHO, EUA for a vaccine is granted if at least 50% of volunteers have been fully vaccinated. Their health is monitored continuously for three months after their last injection. This also applies to (imported vaccines),” said Prof. (Prawira-Kartasasmita).

Previously, the Interim Deputy I at Badan POM Togi Hutadjulu explained that an EUA would be granted based on the consideration that the benefits outweigh the risks. The process of evaluating the safety and efficacy of a vaccine candidate involves the National Committee Team for Drug Evaluation (Tim Komite Nasional Penilai Obat), consisting of pharmacologists, clinicians, and experts in various fields. Badan POM would only be able to grant an EUA if a vaccine has met the safety, efficacy and quality requirements based on the evaluation process.

Scroll to top